2014
DOI: 10.18632/oncotarget.2283
|View full text |Cite
|
Sign up to set email alerts
|

N-Myc-induced up-regulation of TRPM6/TRPM7 channels promotes neuroblastoma cell proliferation

Abstract: Intracellular levels of the divalent cations Ca2+ and Mg2+ are important regulators of cell cycle and proliferation. However, the precise mechanisms by which they are regulated in cancer remain incompletely understood. The channel kinases TRPM6 and TRPM7 are gatekeepers of human Ca2+/Mg2+ metabolism. Here, we investigated the human neuroblastoma cell line SHEP-21N in which the MYCN oncogene (encoding N-Myc) can be reversibly expressed under control of an inducible repressor. We report that N-Myc expression inc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(26 citation statements)
references
References 41 publications
2
23
1
Order By: Relevance
“…Moreover, TRPM7 silencing also decreases MCF-7 proliferation in a Ca 2+ -dependent manner. Similar results were found in retinoblastoma (Hanano et al 2004), in head and neck squamous carcinoma (Jiang et al 2007) and in neuroblastoma (Zhang et al 2014) cell lines suggesting that TRPM7 channels promote constitutive Ca 2+ uptake and regulate basal intracellular Ca 2+ levels leading to sustained proliferation of cancer cells.…”
Section: Trpm7 Is Involved In Cancer Cell Fates Through Different Mecsupporting
confidence: 79%
“…Moreover, TRPM7 silencing also decreases MCF-7 proliferation in a Ca 2+ -dependent manner. Similar results were found in retinoblastoma (Hanano et al 2004), in head and neck squamous carcinoma (Jiang et al 2007) and in neuroblastoma (Zhang et al 2014) cell lines suggesting that TRPM7 channels promote constitutive Ca 2+ uptake and regulate basal intracellular Ca 2+ levels leading to sustained proliferation of cancer cells.…”
Section: Trpm7 Is Involved In Cancer Cell Fates Through Different Mecsupporting
confidence: 79%
“…Several types of Ca 2ϩ entry and Ca 2ϩ release channels have been implicated in such remodeling in various cancer types (FIGURE 2, blue color). Among them are ORAI1 and STIM1 SOC components (78,136,218,260,308,420,558,569); TRP members TRPV6 (44,136,289,290,420), TRPC1, TRPC3, TRPC4 and TRPC6 (15, 19, 85, 117-119, 247, 458, 460, 485, 487, 557), TRPM2 (556), TRPM6/7 (117,190,475,554,560); Ca v family members (58,381,562); as well as IP 3 R (436,481) and RyR (3) ER release channels. Most of the relevant data, however, were obtained by comparing respective channels mRNA expression in normal and cancer tissues and assaying proliferative activity of related cancer cell lines in the in vitro setting in response to pharmacological or siRNA-mediated impairment of channels function and/or expression.…”
Section: Oncogenic Alterations In Ca 2ϩ Signalingmentioning
confidence: 99%
“…In addition, TRPM6 mutation (p.R1122Q) affecting its topological domain towards the cytoplasm occurs in a small proportion of breast cancer patients , and two other TRPM6 somatic mutations (p.T1822A and p.A1765T) have also been observed in an independent cohort of breast cancer samples (Stephens et al, 2012). heteromer (Zhang et al, 2014a). Such heteromerization leads to further functional diversification and assessment of both TRPM6 and TRPM7 oncogenic properties might also need to consider the presence and relevance of TRPM6/7 heteromers especially when both channels are expressed in the same cancer cells.…”
Section: Trpm5: a Potential Oncochannel In Melanomamentioning
confidence: 99%